Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-05-07

Clinical Trial Update: VE303 for Treatment of Hepatic Encephalopathy (HE) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial results for VE303 in hepatic encephalopathy have been posted after completion of the study. The trial enrolled patients with cirrhosis an…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • VE303

Snippet

Sponsor: Patricia Bloom | Conditions: Cirrhosis, Hepatic Encephalopathy | Phase 2 | Status: COMPLETED | Results posted: 2024-05-07